David Wohlberg
Private Equity Investor bei Israel Investment Fund Group LLC
Profil
David is a graduate of Yale Law School, where he was an editor of the Yale Law Journal, and a practicing corporate and securities lawyer.
In addition to his legal practice, he has helped to finance, organize, manage and grow several startups and emerging growth companies.
These companies have raised more than $400 million from individual investors and investment banks including Jefferies, Cowen, Piper Jaffray, Oppenheimer and Maxim.
David has previously served as president of a NASDAQ- listed immuno-oncology company, and is currently an officer and director of a private clinical-stage ophthalmology company developing treatments for rare retinal diseases.
?David currently is the Treasurer and a member of the board of Synagogue for the Performing Arts, Rabbi Joseph Telushkin’s shul in Los Angeles.
He is rated 5.0 out of 5 by Martindale-Hubbell and was named a California Super Lawyer in 2005 and 2006.
Aktive Positionen von David Wohlberg
| Unternehmen | Position | Beginn |
|---|---|---|
Israel Investment Fund Group LLC
 Israel Investment Fund Group LLC Investment ManagersFinance Israel Investment Fund Group LLC (IIFG) is an private equity/venture capital firm founded in 2018 by Hiri Etessami. The firm is headquartered in Beverly Hills, CA. | Private Equity Investor | - |
Ehemalige bekannte Positionen von David Wohlberg
| Unternehmen | Position | Ende |
|---|---|---|
Spectral Molecular Imaging, Inc.
 Spectral Molecular Imaging, Inc. Medical SpecialtiesHealth Technology Spectral Molecular Imaging, Inc. is a medical imaging device company. It manufactures diagnostic imaging products based on spectral optical imaging. The company was founded in 2004 and is located in Los Angeles, CA | Präsident | 02.12.2008 |
| EOM PHARMACEUTICALS HOLDINGS, INC. | Präsident | 29.10.2007 |
Ausbildung von David Wohlberg
| Yale Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
Spectral Molecular Imaging, Inc.
Spectral Molecular Imaging, Inc. Medical SpecialtiesHealth Technology Spectral Molecular Imaging, Inc. is a medical imaging device company. It manufactures diagnostic imaging products based on spectral optical imaging. The company was founded in 2004 and is located in Los Angeles, CA | Health Technology |
Israel Investment Fund Group LLC
Israel Investment Fund Group LLC Investment ManagersFinance Israel Investment Fund Group LLC (IIFG) is an private equity/venture capital firm founded in 2018 by Hiri Etessami. The firm is headquartered in Beverly Hills, CA. | Finance |
